BioLineRx (BLRX) EBIT (2011 - 2025)
BioLineRx's (BLRX) quarterly EBIT came in at -$3.4 million in Q4 2025, up 23.5% year-on-year from -$2.7 million in Q4 2024, and down 53.42% quarter-over-quarter from -$2.2 million in Q3 2025.
BioLineRx (BLRX) EBIT (2011 - 2025) Analysis & Trends
BioLineRx's EBIT history runs 14 years deep, the most recent figure standing at -$3.4 million for Q4 2025.
- On a quarterly basis, EBIT rose 23.5% year-over-year to -$3.4 million in Q4 2025; TTM through Dec 2025 was -$10.3 million, a 49.59% increase from a year earlier, with the FY2025 full-year figure at -$10.3 million, up 49.59% from the prior year.
- EBIT declined to -$3.4 million in Q4 2025 per BLRX's latest filing, from -$2.2 million in the prior quarter.
- Across five years, EBIT topped out at -$2.2 million in Q3 2025 and bottomed at -$18.6 million in Q4 2023.
- The 5-year median for EBIT is -$6.1 million (2021), against an average of -$6.7 million.
- Across the five-year window, EBIT sank 121.08% in 2023 and soared 76.16% in 2024, its largest moves.
- Year by year, EBIT stood at -$6.6 million in 2021, then fell by 27.28% to -$8.4 million in 2022, then sank by 121.08% to -$18.6 million in 2023, then surged by 76.16% to -$4.4 million in 2024, then gained by 23.5% to -$3.4 million in 2025.
- Per Business Quant, the three latest BLRX EBIT figures stand at -$3.4 million (Q4 2025), -$2.2 million (Q3 2025), and -$2.3 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | -3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.39 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -5.39 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.86 Mn |
| Dec 31, 2022 | -8.40 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -6.08 Mn |
| Dec 31, 2021 | -6.60 Mn |
| Sep 30, 2021 | -6.22 Mn |
| Jun 30, 2021 | -6.51 Mn |
| Mar 31, 2021 | -5.45 Mn |